James S Ma, MD | |
10800 Magnolia Ave, Riverside, CA 92505-3043 | |
(909) 353-2000 | |
Not Available |
Full Name | James S Ma |
---|---|
Gender | Male |
Speciality | Gastroenterology |
Experience | 34 Years |
Location | 10800 Magnolia Ave, Riverside, California |
Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
Identifier | Type | State | Issuer |
---|---|---|---|
1295802007 | NPI | - | NPPES |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
207RG0100X | Internal Medicine - Gastroenterology | G74850 (California) | Primary |
Facility Name | Location | Facility Type |
---|---|---|
Kaiser Foundation Hospital, Riverside | Riverside, CA | Hospital |
Group Practice Name | Group PECOS PAC ID | No. of Members |
---|---|---|
Southern California Permanente Medical Group | 6002729175 | 7951 |
News Archive
BerGenBio AS, an oncology biopharmaceutical company, today announces that its multi-centre open label Phase 1b trial (BGBC004) of BGB324, a selective inhibitor of Axl, in patients with Stage IIIb and Stage IV non-small cell lung cancer (NSCLC) in erlotinib-sensitive and refractory patients who have an activating EGFR mutation, is now underway at the University of Texas MD Anderson Cancer Center, Houston, Oncology Partners, Houston, and at UT Southwestern Medical Center, Dallas, Texas, USA.
"Bills in both the Senate and the House of Representatives would make more people eligible for Medicaid, the health insurance program for the poor that states administer with reimbursements from the federal government," Reuters reports.
Mast Therapeutics, Inc. today announced that two posters for its lead product candidate, MST-188, were presented at the 7th Annual Sickle Cell Disease Research & Educational Symposium, currently underway in Miami.
Levels of non-high-density lipoprotein cholesterol (non-HDL-C) among statin-treated patients appears to be associated with the risk of developing a major cardiovascular event, such as a heart attack or stroke, as are levels of low-density lipoprotein cholesterol (LDL-C) and apolipoprotein B, according to a meta-analysis of data from previously published studies appearing in the March 28 issue of JAMA.
The last couple decades have seen a virtual renaissance of neuroscience discovery, largely aided by the advanced technology of functional magnetic resonance imaging (fMRI).
› Verified 8 days ago
Entity Name | Southern California Permanente Medical Group |
---|---|
Entity Type | Part B Supplier - Clinic/group Practice |
Entity Identifiers | NPI Number: 1316979834 PECOS PAC ID: 6002729175 Enrollment ID: O20040126000823 |
News Archive
BerGenBio AS, an oncology biopharmaceutical company, today announces that its multi-centre open label Phase 1b trial (BGBC004) of BGB324, a selective inhibitor of Axl, in patients with Stage IIIb and Stage IV non-small cell lung cancer (NSCLC) in erlotinib-sensitive and refractory patients who have an activating EGFR mutation, is now underway at the University of Texas MD Anderson Cancer Center, Houston, Oncology Partners, Houston, and at UT Southwestern Medical Center, Dallas, Texas, USA.
"Bills in both the Senate and the House of Representatives would make more people eligible for Medicaid, the health insurance program for the poor that states administer with reimbursements from the federal government," Reuters reports.
Mast Therapeutics, Inc. today announced that two posters for its lead product candidate, MST-188, were presented at the 7th Annual Sickle Cell Disease Research & Educational Symposium, currently underway in Miami.
Levels of non-high-density lipoprotein cholesterol (non-HDL-C) among statin-treated patients appears to be associated with the risk of developing a major cardiovascular event, such as a heart attack or stroke, as are levels of low-density lipoprotein cholesterol (LDL-C) and apolipoprotein B, according to a meta-analysis of data from previously published studies appearing in the March 28 issue of JAMA.
The last couple decades have seen a virtual renaissance of neuroscience discovery, largely aided by the advanced technology of functional magnetic resonance imaging (fMRI).
› Verified 8 days ago
Mailing Address | Practice Location Address |
---|---|
James S Ma, MD 10800 Magnolia Ave, Riverside, CA 92505-3043 Ph: (909) 353-2000 | James S Ma, MD 10800 Magnolia Ave, Riverside, CA 92505-3043 Ph: (909) 353-2000 |
News Archive
BerGenBio AS, an oncology biopharmaceutical company, today announces that its multi-centre open label Phase 1b trial (BGBC004) of BGB324, a selective inhibitor of Axl, in patients with Stage IIIb and Stage IV non-small cell lung cancer (NSCLC) in erlotinib-sensitive and refractory patients who have an activating EGFR mutation, is now underway at the University of Texas MD Anderson Cancer Center, Houston, Oncology Partners, Houston, and at UT Southwestern Medical Center, Dallas, Texas, USA.
"Bills in both the Senate and the House of Representatives would make more people eligible for Medicaid, the health insurance program for the poor that states administer with reimbursements from the federal government," Reuters reports.
Mast Therapeutics, Inc. today announced that two posters for its lead product candidate, MST-188, were presented at the 7th Annual Sickle Cell Disease Research & Educational Symposium, currently underway in Miami.
Levels of non-high-density lipoprotein cholesterol (non-HDL-C) among statin-treated patients appears to be associated with the risk of developing a major cardiovascular event, such as a heart attack or stroke, as are levels of low-density lipoprotein cholesterol (LDL-C) and apolipoprotein B, according to a meta-analysis of data from previously published studies appearing in the March 28 issue of JAMA.
The last couple decades have seen a virtual renaissance of neuroscience discovery, largely aided by the advanced technology of functional magnetic resonance imaging (fMRI).
› Verified 8 days ago
Sang Kun Yim, MD Gastroenterology Medicare: Accepting Medicare Assignments Practice Location: 7117 Brockton Ave, Riverside, CA 92506 Phone: 951-683-6370 | |
Sarah Chae, MD Gastroenterology Medicare: Accepting Medicare Assignments Practice Location: 4646 Brockton Ave Ste 201, Riverside, CA 92506 Phone: 951-585-1800 Fax: 951-585-1801 | |
Alina S Popa, MD Gastroenterology Medicare: Accepting Medicare Assignments Practice Location: 4445 Magnolia Ave, Riverside, CA 92501 Phone: 951-788-3636 | |
Richard M. Bradburne, MD Gastroenterology Medicare: Accepting Medicare Assignments Practice Location: 10800 Magnolia Ave, Riverside, CA 92505 Phone: 909-353-2000 | |
Shelly C. Thio, MD Gastroenterology Medicare: Accepting Medicare Assignments Practice Location: 10800 Magnolia Ave, Riverside, CA 92505 Phone: 909-353-2000 | |
Fawaz Gailani, MD Gastroenterology Medicare: Not Enrolled in Medicare Practice Location: 10800 Magnolia Ave, Riverside, CA 92505 Phone: 909-353-2000 | |
Andrew Duke, M.D. Gastroenterology Medicare: Medicare Enrolled Practice Location: 4445 Magnolia Ave, Riverside, CA 92501 Phone: 951-788-3000 |